BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24016310)

  • 1. Lentiviral small hairpin RNA knockdown of macrophage inflammatory protein-1γ ameliorates experimentally induced osteoarthritis in mice.
    Shen PC; Lu CS; Shiau AL; Lee CH; Jou IM; Hsieh JL
    Hum Gene Ther; 2013 Oct; 24(10):871-82. PubMed ID: 24016310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T helper cells promote disease progression of osteoarthritis by inducing macrophage inflammatory protein-1γ.
    Shen PC; Wu CL; Jou IM; Lee CH; Juan HY; Lee PJ; Chen SH; Hsieh JL
    Osteoarthritis Cartilage; 2011 Jun; 19(6):728-36. PubMed ID: 21376128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melittin inhibits osteoclast formation through the downregulation of the RANKL-RANK signaling pathway and the inhibition of interleukin-1β in murine macrophages.
    Choe JY; Kim SK
    Int J Mol Med; 2017 Mar; 39(3):539-548. PubMed ID: 28204822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MIP-1 gamma promotes receptor-activator-of-NF-kappa-B-ligand-induced osteoclast formation and survival.
    Okamatsu Y; Kim D; Battaglino R; Sasaki H; Späte U; Stashenko P
    J Immunol; 2004 Aug; 173(3):2084-90. PubMed ID: 15265944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct stimulation of osteoclastogenesis by MIP-1alpha: evidence obtained from studies using RAW264 cell clone highly responsive to RANKL.
    Watanabe T; Kukita T; Kukita A; Wada N; Toh K; Nagata K; Nomiyama H; Iijima T
    J Endocrinol; 2004 Jan; 180(1):193-201. PubMed ID: 14709158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine and chemokine receptor expression during colony stimulating factor-1-induced osteoclast differentiation in the toothless osteopetrotic rat: a key role for CCL9 (MIP-1gamma) in osteoclastogenesis in vivo and in vitro.
    Yang M; Mailhot G; MacKay CA; Mason-Savas A; Aubin J; Odgren PR
    Blood; 2006 Mar; 107(6):2262-70. PubMed ID: 16304045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible involvement of MIP-1alpha in the recruitment of osteoclast progenitors to the distal tibia in rats with adjuvant-induced arthritis.
    Toh K; Kukita T; Wu Z; Kukita A; Sandra F; Tang QY; Nomiyama H; Iijima T
    Lab Invest; 2004 Sep; 84(9):1092-102. PubMed ID: 15195117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
    Yu X; Huang Y; Collin-Osdoby P; Osdoby P
    J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of osteoclastogenesis by RNA interference targeting RANK.
    Ma R; Xu J; Dong B; Kauther MD; Jäger M; Wedemeyer C
    BMC Musculoskelet Disord; 2012 Aug; 13():154. PubMed ID: 22913338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-mediated kallistatin gene transfer ameliorates disease progression in a rat model of osteoarthritis induced by anterior cruciate ligament transection.
    Hsieh JL; Shen PC; Shiau AL; Jou IM; Lee CH; Teo ML; Wang CR; Chao J; Chao L; Wu CL
    Hum Gene Ther; 2009 Feb; 20(2):147-58. PubMed ID: 20377366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCL9/MIP-1gamma and its receptor CCR1 are the major chemokine ligand/receptor species expressed by osteoclasts.
    Lean JM; Murphy C; Fuller K; Chambers TJ
    J Cell Biochem; 2002; 87(4):386-93. PubMed ID: 12397598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technetium-99 conjugated with methylene diphosphonate inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis.
    Gong W; Dou H; Liu X; Sun L; Hou Y
    Clin Exp Pharmacol Physiol; 2012 Oct; 39(10):886-93. PubMed ID: 23013134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of vascular endothelial growth factor with shRNA in chondrocytes ameliorates osteoarthritis.
    Zhang X; Crawford R; Xiao Y
    J Mol Med (Berl); 2016 Jul; 94(7):787-98. PubMed ID: 27164955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of RANKL-induced osteoclast formation in mouse bone marrow cells by IL-12: involvement of IFN-gamma possibly induced from non-T cell population.
    Nagata N; Kitaura H; Yoshida N; Nakayama K
    Bone; 2003 Oct; 33(4):721-32. PubMed ID: 14555278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory Molecule,
    Li J; Zhou Z; Zhang X; Zheng L; He D; Ye Y; Zhang QQ; Qi CL; He XD; Yu C; Shao CK; Qiao L; Wang L
    Mol Cancer Res; 2017 Apr; 15(4):467-477. PubMed ID: 28108624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synovial macrophage-osteoclast differentiation in inflammatory arthritis.
    Danks L; Sabokbar A; Gundle R; Athanasou NA
    Ann Rheum Dis; 2002 Oct; 61(10):916-21. PubMed ID: 12228163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
    Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M
    Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cartilage damage by pro-opiomelanocortin prohormone overexpression in a rat model of osteoarthritis.
    Shen PC; Shiau AL; Jou IM; Lee CH; Tai MH; Juan HY; Lin PR; Liu GS; Wu CL; Hsieh JL
    Exp Biol Med (Maywood); 2011 Mar; 236(3):334-40. PubMed ID: 21378032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kalkitoxin Reduces Osteoclast Formation and Resorption and Protects against Inflammatory Bone Loss.
    Li L; Yang M; Shrestha SK; Kim H; Gerwick WH; Soh Y
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th1/Th17/Th22 immune response and their association with joint pain, imagenological bone loss, RANKL expression and osteoclast activity in temporomandibular joint osteoarthritis: A preliminary report.
    Monasterio G; Castillo F; Rojas L; Cafferata EA; Alvarez C; Carvajal P; Núñez C; Flores G; Díaz W; Vernal R
    J Oral Rehabil; 2018 Aug; 45(8):589-597. PubMed ID: 29761933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.